IM Cannabis (IMCC) Total Debt (2020 - 2025)
IM Cannabis' (IMCC) quarterly Total Debt came in at $10.9 million in Q4 2025, down 2.02% year-on-year from $11.2 million in Q4 2024, and down 2.02% quarter-over-quarter from $11.2 million in Q4 2024.
IM Cannabis (IMCC) Total Debt (2020 - 2025) Analysis & Trends
IM Cannabis' Total Debt history runs 6 years deep, the most recent figure standing at $10.9 million for Q4 2025.
- On a quarterly basis, Total Debt fell 2.02% year-over-year to $10.9 million in Q4 2025; TTM through Dec 2025 was $10.9 million, a 2.02% decrease from a year earlier, with the FY2025 full-year figure at $10.9 million, down 3.97% from the prior year.
- Total Debt fell to $10.9 million in Q4 2025 per IMCC's latest filing, from $11.2 million in the prior quarter.
- Across five years, Total Debt topped out at $11.2 million in Q4 2024 and bottomed at $277656.6 in Q2 2022.
- The 5-year median for Total Debt is $296886.6 (2024), against an average of $2.9 million.
- Across the five-year window, Total Debt jumped 48696.43% in 2021 and slumped 95.93% in 2023, its largest moves.
- Year by year, Total Debt stood at $7.2 million in 2021, then declined by 1.32% to $7.1 million in 2022, then slumped by 95.93% to $289407.0 in 2023, then surged by 3761.39% to $11.2 million in 2024, then decreased by 2.02% to $10.9 million in 2025.
- Per Business Quant, the three latest IMCC Total Debt figures stand at $10.9 million (Q4 2025), $11.2 million (Q4 2024), and $296886.6 (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.95 Mn |
| Dec 31, 2024 | 11.18 Mn |
| Sep 30, 2024 | 296,886.63 |
| Jun 30, 2024 | 293,187.36 |
| Mar 31, 2024 | 297,587.40 |
| Dec 31, 2023 | 289,407.00 |
| Sep 30, 2023 | 280,469.86 |
| Jun 30, 2023 | 282,147.48 |
| Mar 31, 2023 | 290,700.67 |
| Dec 31, 2022 | 7.11 Mn |
| Sep 30, 2022 | 283,696.11 |
| Jun 30, 2022 | 277,656.59 |
| Mar 31, 2022 | 298,421.70 |
| Dec 31, 2021 | 7.20 Mn |
| Sep 30, 2021 | 4.91 Mn |
| Dec 31, 2020 | 14,755.83 |